recent
year
mammalian
cell
use
product
recombin
protein
antibodi
virus
viralsubunit
protein
genetherapi
vector
addit
use
commerci
biotechnolog
mammalian
cell
system
serv
mean
examin
fundament
aspect
gene
replic
transcript
translat
posttransl
protein
process
avail
transform
cell
line
along
viral
plasmidbas
mammaliancel
vector
system
provid
tool
import
aspect
mammalian
gene
function
investig
follow
typic
use
mammalian
express
system
verif
clone
gene
product
analysi
effect
protein
express
cell
physiolog
product
isol
gene
cdna
librari
product
correctli
fold
glycosyl
protein
assess
biolog
activ
vitro
vivo
system
product
suitabl
quantiti
protein
glycoprotein
structur
character
protein
carbohydr
moieti
product
import
clinic
activ
viral
surfac
antigenseg
prehepat
b
viru
surfac
antigen
hbvsag
well
therapeut
proteinseg
tissu
plasminogen
activ
tpa
erythropoietin
epo
factor
viii
product
monoclon
antibodi
import
featur
mammalian
cell
includ
abil
perform
posttransl
modif
secret
glycoprotein
correctli
fold
contain
complex
antennari
oligosaccharid
termin
sialic
acid
coval
modif
may
modul
clinic
efficaci
protein
eg
circulatori
halflif
biospecif
result
properti
interest
biochem
characterizationeg
respect
structur
stabil
function
group
biolog
role
mammalianproduc
protein
qualitycontrol
process
wherebi
progress
incomplet
fold
misassembl
unassembl
protein
secretori
pathway
select
inhibit
hurtley
heleniu
correctli
process
materi
progress
gener
secret
fulli
activ
protein
anoth
import
featur
mammalian
cell
express
abil
provid
protein
bear
sialyl
glycoform
close
resembl
glycoprotein
produc
human
contrast
e
coli
possess
glycosyl
machineri
yeast
tend
produc
hypermannosetyp
glycosyl
yeastproduc
glycoprotein
rapidli
clear
circul
liver
also
may
induc
advers
immunogen
respons
human
posttransl
modif
perform
mammalian
cell
includ
proteolyt
process
propeptid
neurath
well
glycosyl
carbohydr
trim
hirschberg
snider
modif
may
includ
carboxyl
glutam
acid
residu
sutti
kaufman
et
al
hydroxyl
aspart
acid
asparagin
residu
stenflo
sulfat
tyrosin
residu
baeuerl
huttner
phosphoryl
protein
cell
receptorprotein
interact
myer
et
al
fatti
acid
acyl
mcilhinney
correct
assembl
multimer
protein
contrast
happen
mammalian
cell
product
intracellular
recombin
protein
e
coli
lead
accumul
protein
reduc
form
often
insolubl
refractil
bodi
requir
subsequ
denatur
refold
unit
briefli
review
stage
involv
protein
product
mammalian
cell
use
stableexpress
approach
outlin
figur
discuss
includ
choic
cell
type
transfect
host
cell
method
select
amplif
transform
growth
cell
appropri
scale
protein
product
sinc
posttranscript
modif
intracellular
protein
transport
import
featur
recombinantprotein
product
mammalian
cell
descript
mechan
includ
summar
tabl
narrow
choic
larg
due
need
cell
line
capabl
continu
growth
grown
suspens
bioreactor
low
risk
adventiti
infect
potenti
pathogen
virus
genet
stabil
readili
character
respect
karyolog
morpholog
isoenzym
gene
copi
number
exist
varieti
hostcel
system
avail
viral
cdnabas
vector
possibl
either
stabl
transient
express
requir
prospect
user
defin
express
strategi
base
ultim
goal
research
object
requir
mg
protein
transient
express
cell
relev
rout
transient
express
coscel
vaccinia
system
recent
review
moss
earl
aruffo
detail
protocol
construct
suitabl
vector
protein
express
system
found
articl
transient
express
burst
product
occur
host
cell
usual
accompa
nie
death
rapid
lysi
cell
present
purif
scientist
challeng
fish
protein
interest
may
present
soup
lyse
cellular
protein
nucleic
acid
viral
particl
yield
product
purif
may
low
result
low
titer
start
puriti
howev
small
quantiti
protein
requir
transient
express
co
cell
vaccinia
system
quick
suitabl
system
employ
product
larger
quantiti
protein
stabl
express
must
use
difficulti
scale
transient
express
bioreactor
system
stabl
express
chines
hamster
ovari
cho
cell
describ
unit
cell
line
success
use
host
product
virus
use
protein
includ
human
embryon
lung
cell
line
normal
embryon
cell
line
cell
attach
growthdepend
finit
lifespan
gener
time
cell
enter
senesc
phase
begin
die
cell
line
undergon
transform
viru
experienc
alter
chromosom
exhibit
capac
infinit
growth
well
abil
grow
suspens
exampl
cell
line
hela
cell
human
cervic
cancer
namalwa
cell
human
lymphoma
reluct
use
cell
line
product
clinic
agent
possibl
transfer
tumorigen
agent
product
product
larger
amount
recombin
protein
stabl
express
requir
primarili
perform
cho
cell
babi
hamster
kidney
cell
myeloma
cell
eg
nso
cell
line
capabl
indefinit
growth
larg
scale
suitabl
host
stabl
integr
heterolog
dna
stabl
express
result
integr
hostcel
genom
gene
express
heterolog
protein
integr
gene
transcrib
effici
protein
express
persist
mani
gener
host
cell
stabl
producercel
line
typic
provid
mg
secret
protein
per
cell
per
day
specif
product
monoclon
antibodi
product
product
level
mg
per
viabl
cell
per
day
myeloma
cell
bebbington
et
al
shitara
et
al
mg
per
viabl
cell
per
day
cho
cell
page
sydenham
obtain
level
may
allow
secretedantibodi
titer
mgliter
achiev
optim
largescal
system
henc
system
popular
biotechnolog
protein
accumul
intracellularli
may
reach
littl
total
cell
protein
thu
focu
tend
secret
protein
signific
amount
product
obtain
obviou
drawback
associ
stabl
express
mammalian
cell
time
requir
obtain
stabl
product
cell
bank
month
versu
requir
obtain
larg
amount
nonposttransl
modifi
protein
e
coli
larg
quantiti
highmannosecontain
glycoprotein
use
yeast
insect
cell
week
advantag
obtain
complex
protein
mammalian
cell
includ
abil
understand
molecul
interact
biolog
model
vitro
vivo
use
mammalian
system
much
knowledg
gain
understand
posttransl
modif
protein
qualiti
control
protein
transloc
knowledg
ultim
facilit
improv
express
mammalian
host
stabl
express
requir
transfer
foreign
dna
along
relev
dnabas
signal
transcript
rna
polymeras
ii
chromosom
dna
host
cell
eg
cho
suitabl
plasmid
vector
requir
carri
function
host
dna
vector
commerci
avail
varieti
vendorseg
invitrogen
clontech
promega
see
supplier
appendix
larg
varieti
vector
describ
pouwel
et
al
suitabl
replicon
contain
kb
dna
usual
design
contain
phenotyp
marker
select
e
coli
eg
ap
r
cho
cell
dhfr
featur
appropri
plasmid
includ
promoterdist
clone
site
along
clone
site
replic
origin
e
coli
polyadenyl
sequenc
bovin
growth
hormon
eukaryot
origin
replic
eg
orip
gene
express
protein
site
proxim
promot
promot
associ
element
commonli
use
constitut
promot
cho
cell
applic
earli
promot
moreau
et
al
neuhau
et
al
adenoviru
late
promot
mcknight
tjian
cytomegaloviru
cmv
earli
promot
boshart
et
al
transcript
enhanc
human
cmv
enhanc
boshart
et
al
enhanc
transcript
activ
may
incorpor
vector
featur
illustr
figur
cho
cell
use
extens
host
stabl
express
protein
number
cho
mutant
develop
provid
user
tool
examin
synthesi
dna
rna
protein
well
protein
secret
protein
glycosyl
intermediari
metabol
popular
cho
sublin
also
see
urlaub
chasin
cho
dhfr
dhfr
cho
dhfr
dhfr
cell
deriv
lawrenc
chasin
cell
origin
deriv
cell
use
chasin
laboratori
develop
line
obtain
ted
puck
faten
kao
eleanor
roosevelt
cancer
institut
denver
cell
line
contain
doubl
mutat
dhfr
gene
capabl
natur
revers
dhfr
phenotyp
cell
line
deriv
cho
cell
chasin
cho
deriv
cell
line
establish
sometim
refer
cho
toronto
use
extens
citi
loui
siminivitch
colleagu
cell
line
obtain
dr
lawrenc
chasin
columbia
univers
email
columbiaedu
mutant
produc
brief
list
includ
wirth
hauser
introduct
genet
materi
mammalian
cell
three
type
vector
availablevirus
plasmid
vector
replicon
anim
cell
plasmid
vector
without
replicon
anim
cell
virus
replic
mammalian
cell
ultim
caus
death
lysi
host
cell
express
virusborn
gene
transient
obtain
short
period
prior
lysi
retrovirus
capabl
integr
genet
materi
chromosom
host
cellsi
stabl
transform
virus
use
plasmid
vector
result
either
stabl
transient
express
gene
product
plasmid
vector
without
mam
tsang
et
al
adapt
permiss
plasmid
two
multipl
clone
site
mcss
three
promot
one
promot
drive
neomycinresist
protein
remain
two
mcss
specif
promot
use
incorpor
amplif
marker
dhfr
gene
protein
interest
malian
cell
replicon
would
requir
stabl
integr
express
gene
product
stabl
product
foreign
protein
mammalian
cell
requir
use
host
cell
line
capabl
incorpor
heterologousgen
dna
chromosom
addit
need
success
stabl
integr
select
method
need
fish
stabl
transform
larg
popul
cell
may
contain
unstabl
intracellular
heterolog
gene
copi
necessit
cotransfect
gene
confer
uniqu
phenotyp
properti
resist
cytotox
drug
frequent
appli
method
select
stabl
transform
normal
gene
recess
drug
resist
would
cotransfect
host
cell
defici
particular
activ
common
approach
use
dihydrofol
reductas
dhfr
use
select
marker
dhfrdefici
cho
cell
kaufman
sharp
common
transfect
select
amplif
marker
use
cho
cell
adenosin
deaminas
presenc
inhibitor
ada
cytotox
level
adenin
analog
cho
dhfr
yeung
et
al
kaufman
et
al
carbamyl
phosphat
synthetaseaspart
transcarbamylasedihydroorotas
cho
urda
mutant
cell
de
saint
vincent
et
al
asparagin
synthetas
cho
cell
cartier
stanner
glutamin
synthetas
cho
cell
bebbington
hentschel
ornithin
decarboxylas
cho
odc
chiang
mcconlogu
multipl
drug
resist
cho
cell
kane
et
al
mutant
dhfr
leu
chang
arg
use
cho
cell
host
simonsen
levinson
see
mortensen
et
al
addit
discuss
use
select
marker
mammalian
cell
report
highli
variabl
typic
larg
fraction
cho
clone
establish
calcium
phosphateor
lipofectionmedi
cotransfect
dhfr
heterolog
protein
gene
coexpress
dualtransfect
express
vector
wurm
petropoulo
like
integr
occur
random
site
given
mammaliancel
genom
larg
bp
dna
singlecopi
genom
dna
contain
code
sequenc
critic
exert
select
pressur
screen
larg
number
nonproduct
clone
amplif
presenc
select
pressur
necessari
obtain
clone
multipl
copi
heterolog
gene
obtain
coamplif
dhfr
select
marker
gene
respect
wise
screen
high
produc
moder
level
methotrex
prevent
enrich
highcopynumb
unstabl
integrand
stabil
assess
determin
product
extend
growth
passag
absenc
select
pressur
complet
medium
follow
transfect
cell
use
calcium
phosphat
precipit
lipofect
kaufman
cell
popul
acquir
dna
transient
express
encod
protein
period
day
unstabl
nonintegr
dna
lost
cell
smaller
portion
cell
integr
dna
chromosom
result
stabl
protein
express
follow
select
stableexpress
cell
applic
select
pressur
less
equal
approxim
origin
popul
express
foreign
protein
thu
imper
use
select
pressur
product
earli
stableexpress
clone
prevent
overgrowth
nonproduc
cell
cho
dhfr
hostbas
product
cell
grown
medium
defici
nucleosid
eg
medium
life
technolog
contain
serum
dialyz
remov
lowmolecularweight
nucleosid
hypoxanthin
supplement
methotrex
defici
medium
cell
requir
purin
pyrimidin
nucleosid
satisfi
action
heterolog
dihydrofol
reductas
convert
folat
medium
tetrahydrofol
fh
fh
serin
use
cellular
serin
hydroxymethyl
transferas
provid
methylenefh
go
donat
unit
reaction
requir
inosin
acid
thymidin
product
cell
acquir
capac
express
dhfr
select
medium
defici
nucleosid
stepwis
increas
methotrex
concentr
increas
passag
defici
medium
select
cell
contain
high
copi
number
dhfr
kaufman
nucleu
transcript
progress
cytoplasm
translat
transloc
endoplasm
reticulum
er
occur
protein
contain
sequenc
motif
order
specif
posttransl
modif
protein
progress
er
golgi
reach
final
destin
either
secret
protein
special
resid
cellular
protein
see
tabl
gener
initi
genetranscript
ratelimit
step
rate
transcript
elong
constant
movement
rna
polymeras
ii
stop
termin
signal
follow
highli
express
gene
would
distinguish
presenc
high
densiti
polymeras
molecul
result
highfrequ
initi
recombin
protein
destin
secret
transloc
express
protein
follow
socal
constitut
rout
walter
lingappa
shown
part
figur
signalrecognit
particl
srp
bind
signal
sequenc
grow
peptid
protrud
cytoplasm
therebi
halt
synthesi
protein
ribosomesrp
complex
bound
dock
protein
srp
receptor
er
membran
protein
synthesi
continu
peptid
chain
progress
lumen
er
point
aminotermin
signal
sequenc
cleav
signal
peptid
encompass
amino
acid
usual
net
posit
charg
n
terminu
core
nine
hydrophob
amino
acid
cleavag
site
von
heijn
tissu
plasminogen
activ
membran
anchoringeg
hbv
mcilhinney
tyr
golgi
sulfat
biolog
function
rosenquist
nichola
han
martinag
tyr
cellsurfac
kinas
phosphoryl
signal
transduct
viral
proteinseg
hbv
core
myer
et
al
albin
robinson
aitken
asn
asp
golgi
hydroxyl
biolog
function
stenflo
et
al
glu
golgi
calcium
bindingeg
bloodcascad
factor
sutti
kaufman
et
al
current
protocol
protein
scienc
supplement
tpa
leader
peptid
use
effici
transloc
burk
et
al
protein
fold
glycosyl
initi
er
detail
discuss
intracellular
factor
involv
protein
transloc
given
number
excel
review
geth
sambrook
rothman
orci
wirth
hauser
rothman
protein
begin
fold
cotransl
er
er
provid
environ
optim
protein
fold
distinguish
rel
high
concentr
calcium
baumann
et
al
fold
stabil
protein
calciumdepend
lodish
kong
anoth
signific
featur
er
redox
potenti
suffici
high
enabl
disulfidebond
format
hwang
et
al
circl
ii
circl
circl
glcnac
transferas
circl
ii
circl
glcnac
transferas
ii
circl
transferas
circl
transferas
circl
transferas
glutathion
redox
buffer
redox
potenti
er
time
oxid
cytosol
indic
gshgssg
ratio
er
compar
cytosol
hwang
et
al
er
contain
solubl
fold
enzym
protein
disulfid
isomeras
pdi
prolyl
isomeras
serv
aid
refold
process
anoth
group
protein
known
chaperon
elli
hemmingsen
present
er
appear
assist
protein
fold
ensur
incorrectli
fold
protein
releas
er
thu
play
qualityassur
role
newli
synthes
protein
cell
beststudi
chaperon
glucos
respons
protein
bip
grp
member
famili
protein
munro
pelham
hendershot
et
al
er
integr
membran
protein
call
calnexin
bergeron
et
al
also
appear
function
qualiti
control
protein
fold
er
affect
retent
incorrectli
fold
protein
calnexin
unrel
heatshock
chaperon
famili
protein
fold
er
nlink
oligosaccharid
ad
nascent
chain
via
dolichol
phosphat
intramolecular
disulfid
bond
form
assist
protein
disulfid
isomeras
pdi
molecular
chaperon
associ
refold
peptid
chain
multipl
cycl
bip
bind
releas
occur
process
requir
atp
protein
fold
occur
high
effici
halftim
order
min
pulsechas
studi
hepat
b
surfac
antigen
hbvsag
secret
mous
fibroblast
cell
huovila
et
al
show
format
hbvsag
dimer
er
occur
rapidli
within
min
format
higherord
oligom
occur
halftim
hr
studi
also
provid
evid
ratelimit
step
like
passag
er
golgi
matur
intracellular
glycosyl
hbv
detect
higherord
assembl
subunit
assembl
multimer
protein
begin
er
like
complet
socal
ompart
name
accumul
molecul
low
temperatur
appear
case
hbvsag
huovila
et
al
monomer
subunit
extens
fold
bip
dissoci
multimer
protein
viral
membran
protein
subunitsubunit
recognit
assembl
occur
prior
transport
golgi
complex
dom
et
al
correctli
fold
protein
progress
er
golgi
apparatu
protein
may
misfold
result
ineffici
fold
mutat
heat
shock
energi
deplet
addit
exogen
reduct
dithiothreitol
misfold
protein
usual
form
aggreg
typic
display
perman
stabl
associ
bip
aggreg
eventu
degrad
unless
salvag
pathway
facilit
refold
misfold
protein
speci
specif
conditionseg
alter
temperatur
temperaturesensit
fold
mutant
er
environ
experiment
alter
protein
success
fold
er
destin
secret
plasma
membran
intracellular
compart
includ
er
protein
destin
retain
er
possess
ctermin
signal
sequenc
kdel
munro
pelham
protein
contain
kdel
signal
escap
er
effici
salvag
golgi
dival
cationdepend
receptorbas
salvag
pathway
rothman
orci
protein
destin
integr
er
membran
signal
consist
two
lysin
residu
separ
three
four
five
amino
acid
apart
c
terminu
jackson
et
al
signal
golgi
retent
appear
involv
histidin
cystein
within
membranespan
domain
aoki
et
al
nlink
oligosaccharid
assembl
begin
er
compart
kornfeld
kornfeld
brief
nlink
glycosyl
begin
synthesi
lipidlink
oligosaccharid
moietyglc
man
glcnac
ppdolicholwhich
transfer
nascent
peptid
chain
relev
asnxserthr
sequon
site
ie
peptid
sequenc
recognit
site
truncat
initi
oligosaccharid
structur
follow
initi
step
er
fold
primaryglycosyl
protein
transport
golgi
matur
carbohydr
chain
take
place
oglycosyl
thought
occur
nglycosyl
er
earli
part
golgi
differ
glycosyl
given
protein
result
diverg
golgibas
process
oligosaccharid
differ
cell
type
jenkin
et
al
human
lymphoblastoid
namalwa
cell
line
perform
oand
nlink
glycosyl
recombin
tpa
effici
produc
humantyp
glycosyl
characterist
okamoto
et
al
khan
et
al
cho
cell
line
current
protocol
protein
scienc
supplement
product
recombin
protein
use
product
recombin
protein
possess
activ
although
gene
present
cell
make
low
level
galactosamin
neuramin
acid
cho
bhk
cell
also
lack
function
enzym
synthes
exclus
termin
sialic
acid
via
contrast
human
cell
line
contain
enzym
lee
et
al
cho
cell
domin
sialic
acid
found
nacetyl
neuramin
acid
transport
protein
secretori
endocyt
pathway
mediat
small
vesicl
bud
one
compart
fuse
next
compart
rothman
orci
ci
golgi
stack
cgn
tran
golgi
stack
tgn
defin
area
entir
golgi
network
cgn
tgn
constitut
entri
exit
face
respect
involv
sort
distribut
protein
cgn
includ
kdel
salvag
pathway
erbas
protein
tgn
protein
differ
final
destinationseg
lysosom
secretori
vesicl
plasma
membranediverg
golgi
consist
stack
cisterna
carbohydratechain
trim
elong
well
coval
modif
occur
mechan
flow
golgi
cisterna
appear
involv
assembl
coat
vesicl
transfer
next
compart
concomit
loss
coat
loss
coat
link
gtpdepend
hydrolysi
subsequ
fusion
destin
cisterna
atpdepend
also
involv
nethylmaleimid
nem
sensit
enzym
specif
vesicl
target
involv
dock
mechan
base
bind
solubl
nemsensit
attach
protein
snap
receptor
design
snare
heterogen
snare
famili
allow
special
abil
direct
given
protein
appropri
direct
select
fusion
progress
cisterna
ultim
destin
membran
although
usual
desir
obtain
secret
protein
cell
prior
purif
case
goal
may
express
protein
receptor
would
transport
cellsurfac
membran
describ
product
erythropoietin
epo
receptor
epor
transfect
hematopoiet
cell
hilton
et
al
polypeptid
mutat
improv
epor
refold
er
increas
cellsurfac
express
protein
obtain
crude
extract
cell
cultur
medium
follow
complet
cell
cultur
process
glycoprotein
may
purifi
physicochem
analysi
test
biolog
assay
anim
studi
protein
normal
secret
mammalian
cell
case
erresid
protein
bip
prolyl
isomeras
protein
disulfid
isomeras
contain
ctermin
erretent
peptid
sequenc
kdel
also
number
protein
includ
receptor
signaltransduct
protein
express
retain
cell
cell
surfac
case
specif
inhibitor
glycosyl
enzym
ad
cultur
medium
protein
normal
secret
may
poorli
secret
thu
accumul
er
golgi
cell
hickman
kornfeld
releas
intracellular
surfac
protein
requir
disrupt
cell
use
method
capabl
break
cell
membran
homogen
case
membran
associ
expect
nonion
deterg
vv
use
lysi
buffer
coval
modif
amino
acid
mammalian
cell
numer
extent
may
featur
particular
cell
type
exampl
carboxyl
factor
viii
essenti
clottingcascad
activ
accomplish
bhk
human
cell
line
microsomebas
vitamin
kdepend
modif
nonfunct
cho
cell
transform
complement
gene
carboxyl
wirth
hauser
process
event
occur
passag
protein
er
golgi
involv
remov
certain
residu
carbohydr
chainseg
glucos
mannos
trim
sugar
ad
carbohydr
chain
protein
pass
medial
tran
golgieg
addit
nacetylglucosamin
galactosenacet
fucos
galactos
sialic
acid
olink
glycosyl
import
stabil
proteinseg
lowdensitylipoprotein
ldl
receptor
kingsley
et
al
mammalian
cell
cultur
media
complex
comparison
simpl
defin
media
use
propag
bacteria
yeast
complex
stem
need
satisfi
mani
function
requir
normal
growth
supplement
current
protocol
protein
scienc
overview
protein
express
mammalian
cell
metabol
mammalian
cell
bettger
mckeehan
nutrient
must
satisfi
requir
growth
mainten
cell
express
product
addit
specif
growth
factor
insulin
insulinlik
growth
factor
igf
usual
requir
minim
nutrit
requir
first
defin
eagl
earli
studi
show
thirteen
amino
acid
arg
cy
gln
ile
leu
ly
met
phe
thr
trp
tyr
val
eight
vitamin
biotin
folic
acid
niacinamid
pantothen
acid
pyridoxin
riboflavin
thiamin
variou
salt
miner
na
k
ca
mg
cl
po
fe
zn
se
possibl
cu
mn
mo
v
usual
present
trace
contamin
requir
commonli
use
cho
deriv
absolut
requir
prolin
result
genet
defici
convers
glutam
acid
glutam
inorgan
ion
may
function
catalyst
exert
physiolog
effect
glucos
mm
glutamin
mm
commonli
use
provid
energi
sourc
cell
consum
rate
proport
viablecel
concentr
cultur
mammalian
cell
use
complet
tricarboxcyl
acid
tca
cycl
glucoseconsumpt
rate
lower
glutamin
consumpt
rate
consumpt
glucos
yield
lactat
consumpt
glutamin
yield
ammonia
metabol
byproduct
nutrient
consum
rate
proport
rate
increas
cell
densiti
yieldbas
uptak
rate
amino
acid
cho
dg
cell
rang
mm
cell
mm
cell
specif
growth
rate
rate
growth
divid
cell
densiti
day
gray
unpub
observ
reflect
rel
incorpor
frequenc
individu
amino
acid
gener
protein
cho
cell
like
mammalian
cell
produc
alanin
result
glutaminolysi
accumul
ammonia
result
glutamin
degrad
medium
consumpt
cell
may
becom
inhibitori
cell
growth
ultim
limit
densiti
cultur
butler
spier
addit
physiolog
paramet
ph
osmol
redox
potenti
must
kept
within
accept
limit
use
serum
often
advoc
regard
sourc
import
compon
hormon
lipid
growth
factor
serumborn
ingredi
provid
consum
nutrit
compon
well
mitogen
growth
factor
overal
consum
cell
klinman
mckearn
level
complic
mammaliancel
medium
design
occur
need
maintain
balanc
relationship
nutrient
maintain
osmol
medium
within
physiolog
constraint
mosmolkg
recent
medium
develop
focus
reduc
need
high
level
serum
jaym
fetal
bovin
serum
fb
frequent
use
version
serum
obtain
hyclon
see
supplier
appendix
fb
cost
per
liter
factor
contribut
high
cost
produc
commerci
clinic
lot
protein
may
batchtobatch
variat
serum
necessit
screen
small
tflask
shakeflask
growth
studi
chosen
mammalian
cell
line
serum
contain
mgml
protein
albumin
thu
serum
ad
medium
level
initi
exogen
protein
media
would
mgml
growth
cell
low
serum
vv
accomplish
stepwis
adapt
cell
growth
medium
low
zero
serum
import
function
serum
replac
addit
lipid
precursor
cholin
inositol
ethanolamin
polyamin
putrescin
recombin
insulin
nucellinzn
eli
lilli
mgliter
jenkin
along
fecl
citrat
keenan
clyne
number
serumfre
media
develop
commerci
avail
eg
biowhittak
anoth
approach
implement
proteinfre
media
genet
modif
cho
cell
incorpor
heterolog
gene
code
transferrin
pak
et
al
result
cellular
express
transferrin
cell
abl
grow
without
addit
exogen
protein
modifi
medium
supplement
sodium
selenit
major
concern
produc
recombin
protein
proteinfre
medium
potenti
proteolysi
glycosidas
activ
activ
result
process
polypeptid
chain
degrad
carbohydr
moieti
gramer
gooche
teig
et
al
serum
contain
endogen
proteas
inhibitorseg
macroglubulin
barrett
reason
may
valuabl
reagent
right
cell
cultur
media
current
protocol
protein
scienc
supplement
product
recombin
protein
produc
protein
suscept
proteolysi
sialidas
retain
signific
activ
ph
activ
cell
cultur
supernat
caution
taken
minim
cell
lysi
cultur
process
goal
minim
desialyl
express
protein
may
achiev
harvest
supernat
exponentialgrowth
phase
prior
begin
decreasingvi
phase
chill
ad
sialidas
inhibitor
acid
supernat
gramer
et
al
batch
cultur
serumfre
medium
cell
viabil
may
decreas
rapidli
end
cultur
therebi
releas
intracellular
proteas
glycosidas
cultur
medium
may
turn
caus
rapid
proteolysi
carbohydr
degrad
product
product
sialyl
form
glycoprotein
import
clinic
applic
avoid
rapid
clearanc
asialoand
asialogalactoprotein
receptor
liver
gene
key
enzym
glycosyl
pathway
transfect
cho
cell
lee
et
al
attempt
tailor
glycoform
number
choglycosyl
mutant
made
avail
exhibit
defect
one
step
pathway
stanley
erythropoietin
epo
express
cho
mutant
lec
exhibit
less
heterogen
epo
produc
wildtyp
cho
cell
stanley
studi
cell
glucoselimit
chemostat
cultur
use
medium
low
dilut
rate
day
ie
volum
fresh
medium
ad
reactor
per
day
divid
reactor
medium
volum
show
deviat
specif
growth
rate
dilut
rate
increas
specif
celldeath
rate
ie
rate
cell
death
per
liter
per
day
divid
number
viabl
cell
per
liter
suggest
minimum
specif
growth
rate
day
exist
hayter
et
al
studi
specif
rate
interferon
product
increas
specif
growth
rate
indic
growthrel
product
product
pattern
glycosyl
similar
growth
rate
except
lowest
increas
nonglycosyl
observ
address
use
batch
cultur
leelavatcharama
et
al
conclud
growthassoci
product
reflect
cell
cyclerel
phenomenon
wherebi
lower
growth
rate
result
prolong
cellcycl
time
increas
rel
frequenc
g
cell
cultur
popul
suggest
g
phase
least
product
phase
cell
cycl
cho
cell
similarli
phasespecif
synthesi
dihydrofol
reductas
nontransfect
cell
observ
maximum
peak
dhfr
activ
coincid
maximum
rate
dna
synthesi
late
phase
mariani
et
al
express
recombin
cmv
late
promot
cho
shown
sphase
relat
gu
et
al
like
cho
cell
gener
exhibit
sphase
depend
express
foreign
gene
use
typic
promot
element
cmv
late
promot
direct
correl
specif
heterolog
protein
product
rate
specif
growth
rate
observ
bock
et
al
gu
et
al
growth
rate
increas
ratio
g
g
increas
hooker
et
al
frequenc
cell
product
phase
cultur
increas
given
glycoprotein
produc
cell
cultur
mammalian
cell
present
popul
molecul
exhibit
differ
glycosyl
exist
famili
structur
relat
yet
distinct
carbohydr
chain
make
structur
analysi
distinct
speci
complic
sinc
difficult
separ
purifi
structur
variant
variat
may
result
incomplet
occup
direct
site
protein
carbohydratestructur
variat
impart
cell
via
cell
culturebas
condit
furthermor
action
glycosidas
extracellular
environ
particularli
batch
cultur
may
degrad
carbohydr
structur
secret
glycoprotein
lead
wider
rang
carbohydr
structur
popul
chang
oligosaccharid
glycoprotein
may
lead
diminish
biolog
efficaci
vivoeg
increas
clearanceor
may
enhanc
unwant
antigen
molecul
clinic
applic
gooche
et
al
antibodi
produc
cho
cell
serumcontain
medium
exhibit
galactosyl
compar
antibodi
produc
cell
grown
serumfre
medium
life
et
al
culturemedium
glucos
concentr
affect
degre
glycosyl
produc
cho
cell
continu
cultur
hayter
et
al
lipid
supplement
without
lipid
carrier
lipoprotein
appear
increas
nglycosylationsit
occup
jenkin
et
al
supplement
current
protocol
protein
scienc
overview
protein
express
mammalian
cell
perfus
cultur
cell
produc
recombin
interleukin
mutant
nutrient
limit
ie
glucos
amino
acid
dissolv
led
shortterm
chang
gener
level
glycosyl
specif
type
sugar
incorpor
larg
unchang
gawlitzek
et
al
direct
intervent
cell
physiolog
process
impact
glycosyl
decreas
proteinsynthesi
rate
follow
addit
cyclohexamid
improv
glycosylationsit
occup
recombin
prolactin
produc
cell
shelikoff
et
al
low
concentr
dithiothreitol
prevent
cotransl
disulfidebond
format
er
led
complet
glycosyl
tpa
tripeptid
sequon
normal
exhibit
variabl
occup
allen
et
al
suggest
refold
may
limit
access
glycosyl
site
sodium
butyr
sometim
use
improv
protein
synthesi
chang
glycosyl
induc
glcnactransferas
involv
oglycosyl
datti
denni
increas
sialyltransferas
activ
recombin
cho
cell
chotigeat
et
al
gebert
gray
batch
growth
shake
flask
spinner
flask
may
provid
titer
stabl
produc
cell
line
mgliter
thu
yield
mg
crude
secret
product
may
purifi
cultur
supernat
follow
purif
research
may
recov
protein
thu
small
laboratoryscal
cell
cultur
may
provid
mg
pure
protein
puriti
larger
quantiti
materi
requir
use
bioreactor
ph
dissolv
temperatur
stir
may
control
user
wish
control
cell
growth
rate
product
product
continu
reactor
may
use
fix
dilut
rate
case
high
cell
densiti
desir
mode
oper
would
continu
medium
perfus
cell
retent
bioreactor
tabl
provid
guidanc
like
scale
requir
given
object
bioreactor
environ
may
influenc
product
qualiti
mild
hypoxia
may
decreas
specif
activ
sialyl
transferas
henc
sialyl
oligosaccharid
chain
observ
recombin
human
folliclestimul
hormon
produc
cho
cell
dissolv
oxygen
satur
chotigeat
et
al
appear
ph
valu
within
rang
dramat
effect
glycosyl
clearli
optim
growth
would
requir
control
ph
within
narrow
rang
typic
metabol
byproduct
may
limit
factor
achiev
high
cell
densiti
perfu
product
recombin
protein
sion
cultur
increas
ammonium
ion
concentr
mm
cultur
medium
result
substanti
growth
inhibit
hybridoma
cell
mcqueen
bailey
appear
inhibit
growth
cell
line
like
caus
transport
ammonium
ion
membranebound
ion
pump
ultim
acidif
cytoplasm
martinel
et
al
lower
level
ammonia
mm
may
exert
influenc
glycosyl
andersen
et
al
one
approach
elimin
potenti
inhibit
cell
growth
adapt
nonammoniagen
medium
medium
would
contain
glutam
place
glutamin
hassel
butler
lactat
gener
glucos
also
reach
growth
inhibitori
level
mm
optim
medium
perfus
rate
may
enabl
reduct
level
lactat
ammonia
allow
higher
cell
densiti
lower
glucos
level
may
reduc
yield
lactat
concomit
limit
glycosyl
may
occur
co
may
accumul
highdens
cultur
therebi
exert
inhibitori
effect
cultur
limit
due
co
accumul
may
overcom
choos
optim
sparg
strategi
final
mammalian
cell
weaker
larger
bacteri
cell
limit
degre
agit
import
prevent
cell
damag
death
agit
use
reactor
sampl
handl
cell
damag
gasliquid
interfac
well
bubbl
damag
reduc
ad
low
level
wv
surfact
pluron
polyol
murhamm
gooche
yeast
e
coli
heterolog
protein
express
well
defin
compon
express
system
easili
obtain
mani
commerci
vendor
use
system
enabl
research
obtain
larg
amount
pure
materi
short
period
time
contrast
mammalian
express
system
comprehens
defin
understood
requir
signific
invest
time
heterolog
protein
obtain
present
time
mammalian
express
system
avail
turnkey
catalogbas
system
user
must
defin
compon
particular
applic
although
complex
exist
mammalian
cellbas
system
uniqu
import
product
glycoprotein
possess
oligosaccharid
close
ident
human
origin
protein
secret
mammalian
cell
possess
correct
conform
exhibit
full
biolog
activ
abil
transfer
foreign
dna
cell
enabl
greater
understand
mammalian
cell
transcript
translat
posttransl
machineri
abil
incorpor
foreign
gene
sequenc
mammaliancel
chromosom
abil
grow
mammalian
cell
suspens
largescal
bioreactor
enabl
product
larg
quantiti
pure
clinic
import
protein
